Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Marstacimab by Pfizer for Hemophilia A (Factor VIII Deficiency): Likelihood of Approval
Marstacimab is under clinical development by Pfizer and currently in Pre-Registration for Hemophilia A (Factor VIII Deficiency). According to GlobalData,...
Data Insights
Marstacimab by Pfizer for Hemophilia B (Factor IX Deficiency): Likelihood of Approval
Marstacimab is under clinical development by Pfizer and currently in Pre-Registration for Hemophilia B (Factor IX Deficiency). According to GlobalData,...